Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes
- PMID: 20022110
- DOI: 10.1016/j.leukres.2009.11.015
Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes
Abstract
We reported the different clinical features between Japanese and German refractory anemia (RA) patients in FAB classification. We re-analyzed the clinical features by WHO classification revised in 2008. The frequencies of refractory cytopenia with unilineage dysplasia (RCUD) and myelodysplastic syndrome-unclassified (MDS-U) with pancytopenia in Japanese patients were higher than in German patients (p<0.001). Refractory cytopenia with multilineage dysplasia patients showed the most unfavorable prognosis in both countries. The higher frequencies of MDS-U with pancytopenia and RCUD in Japanese patients may influence the different clinical characteristics between Japanese and German FAB-RA patients.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.Blood. 2005 Oct 15;106(8):2633-40. doi: 10.1182/blood-2005-01-0040. Epub 2005 Jun 21. Blood. 2005. PMID: 15972453
-
[Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases].Rinsho Ketsueki. 2004 Apr;45(4):268-73. Rinsho Ketsueki. 2004. PMID: 15168441 Japanese. No abstract available.
-
A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.Leuk Res. 2003 Mar;27(3):221-9. doi: 10.1016/s0145-2126(02)00096-6. Leuk Res. 2003. PMID: 12537974
-
[Myelodysplastic syndrome classification].Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804. Ann Biol Clin (Paris). 2013. PMID: 23587576 Review. French.
-
[Myelodysplastic syndromes--from FAB to WHO classification].Pol Arch Med Wewn. 2005 Nov;114(5):1128-37. Pol Arch Med Wewn. 2005. PMID: 16789514 Review. Polish. No abstract available.
Cited by
-
Refractory thrombocytopenia and neutropenia: a diagnostic challenge.Mediterr J Hematol Infect Dis. 2015 Feb 18;7(1):e2015018. doi: 10.4084/MJHID.2015.018. eCollection 2015. Mediterr J Hematol Infect Dis. 2015. PMID: 25745545 Free PMC article. Review.
-
Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort.Exp Hematol Oncol. 2014 Aug 23;3:22. doi: 10.1186/2162-3619-3-22. eCollection 2014. Exp Hematol Oncol. 2014. PMID: 25170429 Free PMC article.
-
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).Oncotarget. 2016 Sep 27;7(39):63177-63188. doi: 10.18632/oncotarget.11050. Oncotarget. 2016. PMID: 27527853 Free PMC article.
-
Part 2: Myelodysplastic syndromes - classification systems.Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):262-266. doi: 10.1016/j.htct.2018.05.005. Epub 2018 Jul 2. Hematol Transfus Cell Ther. 2018. PMID: 30128436 Free PMC article. No abstract available.
-
Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems.Turk J Haematol. 2016 Jun 5;33(2):119-26. doi: 10.4274/tjh.2014.0455. Epub 2015 Aug 6. Turk J Haematol. 2016. PMID: 26376664 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous